Argentina begins doling out free 'Viagra'

Argentina has begun distributing a free state-produced version of the erection-boosting drug Viagra for the first time, in a move intended to curb its misuse, health authorities announced Thursday.

They said 200,000 doses of sildenafil, better known under the Viagra brand name, is to be distributed free of charge through the public health network of the province of Santa Fe.

The drug is being produced in Santa Fe by the state-owned LIFSE, which plans to eventually distributed it nationally.

Sildenafil is a hugely popular vasodilator that is used to treat erectile dysfunction in men.

"The most famous medication in the world for improving the quality of life—even though no-one is going to lose their life over it—is the first to be made by the state in Argentina," said Guillermo Cleti, a LIFSE director.

"It's not only to attend to erectile dysfunction in men who need it, but also to avoid the abuse or bad use of the drug and to warn the population about its correct use," he said.

add to favorites email to friend print save as pdf

Related Stories

Canada high court voids Pfizer's Viagra patent

Nov 08, 2012

Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.

Bangladesh doctors urge Viagra production halt

Sep 26, 2012

Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the counter.

Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

5 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments